Genzyme, Roche in EGFR assay deal

Genzyme Corp. (NASDAQ:GENZ) granted Roche (SIX:ROG; OTCQX:RHHBY) a worldwide sublicense to develop a diagnostic assay for the detection of EGFR mutations. Further terms were not disclosed. ...